vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Hyatt Hotels Corp (H). Click either name above to swap in a different company.
Hyatt Hotels Corp is the larger business by last-quarter revenue ($1.8B vs $950.5M, roughly 1.9× Astrana Health, Inc.). Astrana Health, Inc. runs the higher net margin — 0.7% vs -1.1%, a 1.8% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 11.7%). Hyatt Hotels Corp produced more free cash flow last quarter ($236.0M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 2.2%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Hyatt Hotels Corporation, commonly known as Hyatt Hotels & Resorts, is an American multinational hospitality company headquartered in the Riverside Plaza area of Chicago that manages and franchises luxury and business hotels, resorts, and vacation properties. Hyatt Hotels & Resorts is one of the businesses managed by the Pritzker family. Hyatt has more than 1350 hotels and all-inclusive properties in 69 countries, across North America, South America, Europe, Asia, Africa and Australia.
ASTH vs H — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.8B |
| Net Profit | $6.6M | $-20.0M |
| Gross Margin | — | — |
| Operating Margin | 1.9% | 0.4% |
| Net Margin | 0.7% | -1.1% |
| Revenue YoY | 42.9% | 11.7% |
| Net Profit YoY | 184.4% | 64.3% |
| EPS (diluted) | $0.12 | $-0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $1.8B | ||
| Q3 25 | $956.0M | $1.8B | ||
| Q2 25 | $654.8M | $1.8B | ||
| Q1 25 | $620.4M | $1.7B | ||
| Q4 24 | $665.2M | $1.6B | ||
| Q3 24 | $478.7M | $1.6B | ||
| Q2 24 | $486.3M | $1.7B | ||
| Q1 24 | $404.4M | $1.7B |
| Q4 25 | $6.6M | $-20.0M | ||
| Q3 25 | $373.0K | $-49.0M | ||
| Q2 25 | $9.4M | $-3.0M | ||
| Q1 25 | $6.7M | $20.0M | ||
| Q4 24 | $-7.8M | $-56.0M | ||
| Q3 24 | $16.1M | $471.0M | ||
| Q2 24 | $19.2M | $359.0M | ||
| Q1 24 | $14.8M | $522.0M |
| Q4 25 | 1.9% | 0.4% | ||
| Q3 25 | 2.0% | -1.0% | ||
| Q2 25 | 3.1% | 2.1% | ||
| Q1 25 | 3.3% | 3.0% | ||
| Q4 24 | 0.1% | -3.0% | ||
| Q3 24 | 5.9% | 37.3% | ||
| Q2 24 | 6.2% | 27.1% | ||
| Q1 24 | 7.5% | 31.6% |
| Q4 25 | 0.7% | -1.1% | ||
| Q3 25 | 0.0% | -2.7% | ||
| Q2 25 | 1.4% | -0.2% | ||
| Q1 25 | 1.1% | 1.2% | ||
| Q4 24 | -1.2% | -3.5% | ||
| Q3 24 | 3.4% | 28.9% | ||
| Q2 24 | 3.9% | 21.1% | ||
| Q1 24 | 3.7% | 30.5% |
| Q4 25 | $0.12 | $-0.20 | ||
| Q3 25 | $0.01 | $-0.51 | ||
| Q2 25 | $0.19 | $-0.03 | ||
| Q1 25 | $0.14 | $0.19 | ||
| Q4 24 | $-0.14 | $-0.37 | ||
| Q3 24 | $0.33 | $4.63 | ||
| Q2 24 | $0.40 | $3.46 | ||
| Q1 24 | $0.31 | $4.93 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $813.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | $3.3B |
| Total Assets | $2.2B | $14.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $813.0M | ||
| Q3 25 | $463.4M | $749.0M | ||
| Q2 25 | $342.1M | $912.0M | ||
| Q1 25 | $260.9M | $1.8B | ||
| Q4 24 | $290.8M | $1.4B | ||
| Q3 24 | $350.3M | $1.1B | ||
| Q2 24 | $327.7M | $2.0B | ||
| Q1 24 | $337.3M | $794.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | $6.0B | ||
| Q2 25 | — | $6.0B | ||
| Q1 25 | — | $4.3B | ||
| Q4 24 | — | $3.8B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $3.9B | ||
| Q1 24 | — | $3.1B |
| Q4 25 | $779.3M | $3.3B | ||
| Q3 25 | $775.5M | $3.5B | ||
| Q2 25 | $765.5M | $3.6B | ||
| Q1 25 | $745.4M | $3.5B | ||
| Q4 24 | $712.7M | $3.5B | ||
| Q3 24 | $704.6M | $3.7B | ||
| Q2 24 | $678.9M | $3.9B | ||
| Q1 24 | $653.5M | $3.7B |
| Q4 25 | $2.2B | $14.0B | ||
| Q3 25 | $2.2B | $15.7B | ||
| Q2 25 | $1.4B | $15.9B | ||
| Q1 25 | $1.3B | $14.0B | ||
| Q4 24 | $1.4B | $13.3B | ||
| Q3 24 | $1.3B | $11.9B | ||
| Q2 24 | $1.3B | $12.8B | ||
| Q1 24 | $1.2B | $11.7B |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.73× | ||
| Q2 25 | — | 1.69× | ||
| Q1 25 | — | 1.25× | ||
| Q4 24 | — | 1.07× | ||
| Q3 24 | — | 0.85× | ||
| Q2 24 | — | 1.01× | ||
| Q1 24 | — | 0.84× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $313.0M |
| Free Cash FlowOCF − Capex | $-6.0M | $236.0M |
| FCF MarginFCF / Revenue | -0.6% | 13.2% |
| Capex IntensityCapex / Revenue | 0.3% | 4.3% |
| Cash ConversionOCF / Net Profit | -0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $159.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $313.0M | ||
| Q3 25 | $10.0M | $-20.0M | ||
| Q2 25 | $90.9M | $-67.0M | ||
| Q1 25 | $16.6M | $153.0M | ||
| Q4 24 | $-10.9M | $235.0M | ||
| Q3 24 | $34.0M | $-21.0M | ||
| Q2 24 | $23.2M | $177.0M | ||
| Q1 24 | $6.0M | $242.0M |
| Q4 25 | $-6.0M | $236.0M | ||
| Q3 25 | $7.4M | $-89.0M | ||
| Q2 25 | $89.5M | $-111.0M | ||
| Q1 25 | $13.6M | $123.0M | ||
| Q4 24 | $-13.5M | $184.0M | ||
| Q3 24 | $31.7M | $-64.0M | ||
| Q2 24 | $20.4M | $135.0M | ||
| Q1 24 | $5.6M | $208.0M |
| Q4 25 | -0.6% | 13.2% | ||
| Q3 25 | 0.8% | -5.0% | ||
| Q2 25 | 13.7% | -6.1% | ||
| Q1 25 | 2.2% | 7.2% | ||
| Q4 24 | -2.0% | 11.5% | ||
| Q3 24 | 6.6% | -3.9% | ||
| Q2 24 | 4.2% | 7.9% | ||
| Q1 24 | 1.4% | 12.1% |
| Q4 25 | 0.3% | 4.3% | ||
| Q3 25 | 0.3% | 3.9% | ||
| Q2 25 | 0.2% | 2.4% | ||
| Q1 25 | 0.5% | 1.7% | ||
| Q4 24 | 0.4% | 3.2% | ||
| Q3 24 | 0.5% | 2.6% | ||
| Q2 24 | 0.6% | 2.5% | ||
| Q1 24 | 0.1% | 2.0% |
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | 7.65× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | -0.04× | ||
| Q2 24 | 1.21× | 0.49× | ||
| Q1 24 | 0.40× | 0.46× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
H
| Other | $627.0M | 35% |
| Rooms Revenue | $326.0M | 18% |
| Net Fees | $290.0M | 16% |
| Distribution Segment | $177.0M | 10% |
| Franchise And Other Fees | $114.0M | 6% |
| Base Management Fees | $112.0M | 6% |
| Incentive Management Fees | $81.0M | 5% |
| Other Owned And Leased Hotel Revenue | $41.0M | 2% |
| Contra Revenue | $17.0M | 1% |
| Other Revenues | $4.0M | 0% |
